Anb

Biodesign Directory Profile

Kare2_small

Contact Information

(480)727-0457

Karen Kibler

Assistant Research Professor

The Biodesign Institute, Infectious Diseases and Vaccinology

Bio

Publications

  • Kibler, KV,  Gomez, CE, Perdiguero, B, Wong, S, Huynh, T, Holechek, S, Arndt, W, Jimenez, V, Gonzalez-Sanz, R, Denzler, K, Haddad, EK, Wagner, R, Sekaly, RP, Tartaglia, J, Pantaleo, G, Jacobs, BJ, and Esteban, M. Improved NYVAC-Based Vaccine Vectors. PLoS ONE, 2011.
  • E.D. Quakkelaar, A. Redeker, E.K. Haddad, A. Harari, S. Mayo McCaughey, T. Duhen, A. Filali-Mouhim, J.P. Goulet, N.M. Loof, F. Ossendorp, B. Perdiguero, P. Heinen, C.E. Gomez, K. Kibler, D.M. Koelle5, R.P. Sékaly, F. Sallusto, A. Lanzavecchia, G. Pantaleo, M. Esteban, J. Tartaglia, B. Jacobs and C.J.M. Melief. Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS ONE, 2010.
  • Tsen, K.T., Tsen, S.W., Fu, Q., Lindsay, S.M., Kibler, K., Jacobs, B., Wu, T.C., Karanam, B., Jagu, S., Roden, R.B., Hung, C.F., Sankey, O.F., Ramakrishna, B. and Kiang, J.G. (2009) Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laser. J Biomed Opt 14(6), 064042.
  • Jentarra GM, Heck MC, Youn JW, Kibler K, Langland JO, Baskin CR, Ananieva O, Chang Y, Jacobs BL.
    2008. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination. Vaccine, 26(23):2860-72.
  • Gallegos-Orozco JF, Arenas JI, Vargas HE, Kibler KV, Wilkinson JK, Nowicki, M, Radkowski M, Nasseri J, Rakela J, Laskus T. 2006. Selection of different 5'untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection.  J Viral Hep, 13(7):489-98.

Selected Publications

2008

  • Jentarra GM, Heck MC, Youn JW, Kibler K, Langland JO, Baskin CR, Ananieva O, Chang Y, Jacobs BL. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination.. Vaccine (2008) Refereed Articles.

2006

  • Gallegos-Orozco JF, Arenas JI, Vargas HE, Kibler KV, Wilkinson JK, Nowicki, M, Radkowski M, Nasseri J, Rakela J, Laskus T. Selection of different 5'untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection.. J Viral Hep (2006) Refereed Articles.

1999

  • .Y. Jin, V. Giordano, K.V. Kibler, H. Nakano, and K.T. Jeang. Role of Adapter Function in Oncoprotein-mediated Activation of NF-?B. The Journal of Biological Chemistry (1999) Refereed Articles.
  • K.V. Kibler and K. T. Jeang. Taxing the Cellular Capacity for Repair: Human T-Cell Leukemia Virus Type 1, DNA Damage, and Adult T-Cell Leukemia. Journal of the National Cancer Institute (1999) Nonrefereed Articles.

1997

  • K. V. Kibler, T. Shors, K. B. Perkins, C.C. Zeman, M.P. Banaszak, J. Biesterfeldt, J. O. Langland, and B. L. Jacobs. 1997. Double-Stranded RNA Is a Trigger for Apoptosis in Vaccinia Virus-Infected Cells. Journal of Virology, 71(3):1992-2003.. Journal of Virology (1997) Refereed Articles.
  • Teri Shors, Karen V. Kibler, Kim B. Perkins, Renee Seidler-Wulff, Matthew P. Banaszak, and Bertram L. Jacobs.. Complementation of Vaccinia Virus Deleted of the E3L Gene by Mutants of E3L.. Virology (1997) Refereed Articles.